nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—CYP1A1—breast cancer	0.372	1	CbGaD
Thiabendazole—CYP1A1—Toremifene—breast cancer	0.157	0.387	CbGbCtD
Thiabendazole—CYP1A2—Anastrozole—breast cancer	0.0767	0.189	CbGbCtD
Thiabendazole—CYP1A2—Toremifene—breast cancer	0.0702	0.173	CbGbCtD
Thiabendazole—CYP1A1—Tamoxifen—breast cancer	0.0574	0.141	CbGbCtD
Thiabendazole—CYP1A2—Tamoxifen—breast cancer	0.0256	0.0632	CbGbCtD
Thiabendazole—CYP1A2—Fluorouracil—breast cancer	0.0189	0.0465	CbGbCtD
Thiabendazole—Lansoprazole—CYP1B1—breast cancer	0.0012	0.306	CrCbGaD
Thiabendazole—Lansoprazole—ABCG2—breast cancer	0.00083	0.211	CrCbGaD
Thiabendazole—Lansoprazole—CYP1A1—breast cancer	0.00065	0.165	CrCbGaD
Thiabendazole—Lansoprazole—CYP2D6—breast cancer	0.000484	0.123	CrCbGaD
Thiabendazole—Lansoprazole—CYP3A4—breast cancer	0.000415	0.106	CrCbGaD
Thiabendazole—Lansoprazole—ABCB1—breast cancer	0.000346	0.0879	CrCbGaD
Thiabendazole—Flushing—Capecitabine—breast cancer	0.000148	0.00101	CcSEcCtD
Thiabendazole—Dermatitis—Melphalan—breast cancer	0.000148	0.00101	CcSEcCtD
Thiabendazole—Chills—Docetaxel—breast cancer	0.000148	0.00101	CcSEcCtD
Thiabendazole—Asthenia—Vinorelbine—breast cancer	0.000147	0.00101	CcSEcCtD
Thiabendazole—Decreased appetite—Irinotecan—breast cancer	0.000147	0.00101	CcSEcCtD
Thiabendazole—Decreased appetite—Mitoxantrone—breast cancer	0.000147	0.00101	CcSEcCtD
Thiabendazole—Nausea—Vinblastine—breast cancer	0.000147	0.001	CcSEcCtD
Thiabendazole—Somnolence—Gemcitabine—breast cancer	0.000146	0.001	CcSEcCtD
Thiabendazole—Convulsion—Paclitaxel—breast cancer	0.000146	0.001	CcSEcCtD
Thiabendazole—Fatigue—Irinotecan—breast cancer	0.000146	0.000997	CcSEcCtD
Thiabendazole—Fatigue—Mitoxantrone—breast cancer	0.000146	0.000997	CcSEcCtD
Thiabendazole—Vomiting—Goserelin—breast cancer	0.000146	0.000996	CcSEcCtD
Thiabendazole—Pruritus—Vinorelbine—breast cancer	0.000145	0.000992	CcSEcCtD
Thiabendazole—Rash—Goserelin—breast cancer	0.000144	0.000987	CcSEcCtD
Thiabendazole—Hypersensitivity—Thiotepa—breast cancer	0.000144	0.000987	CcSEcCtD
Thiabendazole—Dermatitis—Goserelin—breast cancer	0.000144	0.000986	CcSEcCtD
Thiabendazole—Somnolence—Fluorouracil—breast cancer	0.000144	0.000985	CcSEcCtD
Thiabendazole—Headache—Goserelin—breast cancer	0.000143	0.000981	CcSEcCtD
Thiabendazole—Decreased appetite—Gemcitabine—breast cancer	0.000143	0.00098	CcSEcCtD
Thiabendazole—Chills—Capecitabine—breast cancer	0.000143	0.000978	CcSEcCtD
Thiabendazole—Dyspepsia—Fluorouracil—breast cancer	0.000143	0.000975	CcSEcCtD
Thiabendazole—Nausea—Tamoxifen—breast cancer	0.000142	0.000974	CcSEcCtD
Thiabendazole—Fatigue—Gemcitabine—breast cancer	0.000142	0.000971	CcSEcCtD
Thiabendazole—Decreased appetite—Fluorouracil—breast cancer	0.000141	0.000963	CcSEcCtD
Thiabendazole—Asthenia—Thiotepa—breast cancer	0.000141	0.000961	CcSEcCtD
Thiabendazole—Diarrhoea—Vinorelbine—breast cancer	0.00014	0.00096	CcSEcCtD
Thiabendazole—Nausea—Melphalan—breast cancer	0.000139	0.000954	CcSEcCtD
Thiabendazole—Feeling abnormal—Irinotecan—breast cancer	0.000139	0.000953	CcSEcCtD
Thiabendazole—Feeling abnormal—Mitoxantrone—breast cancer	0.000139	0.000953	CcSEcCtD
Thiabendazole—Confusional state—Paclitaxel—breast cancer	0.000139	0.000951	CcSEcCtD
Thiabendazole—Pruritus—Thiotepa—breast cancer	0.000139	0.000948	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Mitoxantrone—breast cancer	0.000138	0.000946	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Irinotecan—breast cancer	0.000138	0.000946	CcSEcCtD
Thiabendazole—Anaphylactic shock—Paclitaxel—breast cancer	0.000138	0.000943	CcSEcCtD
Thiabendazole—Nausea—Goserelin—breast cancer	0.000136	0.00093	CcSEcCtD
Thiabendazole—Feeling abnormal—Gemcitabine—breast cancer	0.000136	0.000929	CcSEcCtD
Thiabendazole—Dizziness—Vinorelbine—breast cancer	0.000136	0.000927	CcSEcCtD
Thiabendazole—Diarrhoea—Thiotepa—breast cancer	0.000134	0.000916	CcSEcCtD
Thiabendazole—Abdominal pain—Irinotecan—breast cancer	0.000134	0.000914	CcSEcCtD
Thiabendazole—Abdominal pain—Mitoxantrone—breast cancer	0.000134	0.000914	CcSEcCtD
Thiabendazole—Feeling abnormal—Fluorouracil—breast cancer	0.000133	0.000913	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—breast cancer	0.000132	0.000904	CcSEcCtD
Thiabendazole—Anorexia—Paclitaxel—breast cancer	0.000131	0.000899	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—breast cancer	0.000131	0.000896	CcSEcCtD
Thiabendazole—Vision blurred—Capecitabine—breast cancer	0.000131	0.000894	CcSEcCtD
Thiabendazole—Vomiting—Vinorelbine—breast cancer	0.00013	0.000892	CcSEcCtD
Thiabendazole—Dizziness—Thiotepa—breast cancer	0.00013	0.000886	CcSEcCtD
Thiabendazole—Rash—Vinorelbine—breast cancer	0.000129	0.000884	CcSEcCtD
Thiabendazole—Dermatitis—Vinorelbine—breast cancer	0.000129	0.000884	CcSEcCtD
Thiabendazole—Hypotension—Paclitaxel—breast cancer	0.000129	0.000882	CcSEcCtD
Thiabendazole—Headache—Vinorelbine—breast cancer	0.000128	0.000879	CcSEcCtD
Thiabendazole—Leukopenia—Docetaxel—breast cancer	0.000128	0.000877	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—breast cancer	0.000126	0.000862	CcSEcCtD
Thiabendazole—Hyperglycaemia—Epirubicin—breast cancer	0.000125	0.000856	CcSEcCtD
Thiabendazole—Hypersensitivity—Mitoxantrone—breast cancer	0.000125	0.000852	CcSEcCtD
Thiabendazole—Hypersensitivity—Irinotecan—breast cancer	0.000125	0.000852	CcSEcCtD
Thiabendazole—Vomiting—Thiotepa—breast cancer	0.000125	0.000852	CcSEcCtD
Thiabendazole—Leukopenia—Capecitabine—breast cancer	0.000124	0.000849	CcSEcCtD
Thiabendazole—Convulsion—Docetaxel—breast cancer	0.000124	0.000849	CcSEcCtD
Thiabendazole—Drowsiness—Epirubicin—breast cancer	0.000124	0.000846	CcSEcCtD
Thiabendazole—Rash—Thiotepa—breast cancer	0.000123	0.000845	CcSEcCtD
Thiabendazole—Dermatitis—Thiotepa—breast cancer	0.000123	0.000844	CcSEcCtD
Thiabendazole—Headache—Thiotepa—breast cancer	0.000123	0.000839	CcSEcCtD
Thiabendazole—Somnolence—Paclitaxel—breast cancer	0.000123	0.000839	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Epirubicin—breast cancer	0.000123	0.000838	CcSEcCtD
Thiabendazole—Nausea—Vinorelbine—breast cancer	0.000122	0.000833	CcSEcCtD
Thiabendazole—Dyspepsia—Paclitaxel—breast cancer	0.000121	0.00083	CcSEcCtD
Thiabendazole—Asthenia—Irinotecan—breast cancer	0.000121	0.00083	CcSEcCtD
Thiabendazole—Asthenia—Mitoxantrone—breast cancer	0.000121	0.00083	CcSEcCtD
Thiabendazole—Jaundice—Epirubicin—breast cancer	0.000121	0.000824	CcSEcCtD
Thiabendazole—Decreased appetite—Paclitaxel—breast cancer	0.00012	0.00082	CcSEcCtD
Thiabendazole—Hypersensitivity—Fluorouracil—breast cancer	0.000119	0.000816	CcSEcCtD
Thiabendazole—Fatigue—Paclitaxel—breast cancer	0.000119	0.000813	CcSEcCtD
Thiabendazole—Asthenia—Gemcitabine—breast cancer	0.000118	0.000808	CcSEcCtD
Thiabendazole—Haematuria—Epirubicin—breast cancer	0.000118	0.000806	CcSEcCtD
Thiabendazole—Confusional state—Docetaxel—breast cancer	0.000118	0.000806	CcSEcCtD
Thiabendazole—Anaphylactic shock—Docetaxel—breast cancer	0.000117	0.0008	CcSEcCtD
Thiabendazole—Pruritus—Gemcitabine—breast cancer	0.000117	0.000797	CcSEcCtD
Thiabendazole—Nausea—Thiotepa—breast cancer	0.000116	0.000796	CcSEcCtD
Thiabendazole—Hyperglycaemia—Doxorubicin—breast cancer	0.000116	0.000792	CcSEcCtD
Thiabendazole—Diarrhoea—Irinotecan—breast cancer	0.000116	0.000791	CcSEcCtD
Thiabendazole—Diarrhoea—Mitoxantrone—breast cancer	0.000116	0.000791	CcSEcCtD
Thiabendazole—Pruritus—Fluorouracil—breast cancer	0.000115	0.000784	CcSEcCtD
Thiabendazole—Drowsiness—Doxorubicin—breast cancer	0.000114	0.000782	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—breast cancer	0.000114	0.000782	CcSEcCtD
Thiabendazole—Confusional state—Capecitabine—breast cancer	0.000114	0.000781	CcSEcCtD
Thiabendazole—Feeling abnormal—Paclitaxel—breast cancer	0.000114	0.000777	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Doxorubicin—breast cancer	0.000113	0.000776	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Paclitaxel—breast cancer	0.000113	0.000771	CcSEcCtD
Thiabendazole—Diarrhoea—Gemcitabine—breast cancer	0.000113	0.000771	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—breast cancer	0.000112	0.000767	CcSEcCtD
Thiabendazole—Dizziness—Irinotecan—breast cancer	0.000112	0.000765	CcSEcCtD
Thiabendazole—Jaundice—Doxorubicin—breast cancer	0.000112	0.000763	CcSEcCtD
Thiabendazole—Anorexia—Docetaxel—breast cancer	0.000111	0.000762	CcSEcCtD
Thiabendazole—Diarrhoea—Fluorouracil—breast cancer	0.000111	0.000758	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—breast cancer	0.000111	0.000756	CcSEcCtD
Thiabendazole—Hypoaesthesia—Epirubicin—breast cancer	0.00011	0.000755	CcSEcCtD
Thiabendazole—Hypotension—Docetaxel—breast cancer	0.000109	0.000747	CcSEcCtD
Thiabendazole—Haematuria—Doxorubicin—breast cancer	0.000109	0.000746	CcSEcCtD
Thiabendazole—Abdominal pain—Paclitaxel—breast cancer	0.000109	0.000746	CcSEcCtD
Thiabendazole—Anorexia—Capecitabine—breast cancer	0.000108	0.000738	CcSEcCtD
Thiabendazole—Vomiting—Irinotecan—breast cancer	0.000108	0.000735	CcSEcCtD
Thiabendazole—Vomiting—Mitoxantrone—breast cancer	0.000108	0.000735	CcSEcCtD
Thiabendazole—Dizziness—Fluorouracil—breast cancer	0.000107	0.000733	CcSEcCtD
Thiabendazole—Visual impairment—Epirubicin—breast cancer	0.000107	0.000732	CcSEcCtD
Thiabendazole—Rash—Mitoxantrone—breast cancer	0.000107	0.000729	CcSEcCtD
Thiabendazole—Rash—Irinotecan—breast cancer	0.000107	0.000729	CcSEcCtD
Thiabendazole—Dermatitis—Irinotecan—breast cancer	0.000107	0.000729	CcSEcCtD
Thiabendazole—Dermatitis—Mitoxantrone—breast cancer	0.000107	0.000729	CcSEcCtD
Thiabendazole—Chills—Methotrexate—breast cancer	0.000106	0.000728	CcSEcCtD
Thiabendazole—Headache—Mitoxantrone—breast cancer	0.000106	0.000725	CcSEcCtD
Thiabendazole—Headache—Irinotecan—breast cancer	0.000106	0.000725	CcSEcCtD
Thiabendazole—Hypotension—Capecitabine—breast cancer	0.000106	0.000723	CcSEcCtD
Thiabendazole—Erythema multiforme—Epirubicin—breast cancer	0.000105	0.000718	CcSEcCtD
Thiabendazole—Vomiting—Gemcitabine—breast cancer	0.000105	0.000716	CcSEcCtD
Thiabendazole—Somnolence—Docetaxel—breast cancer	0.000104	0.000711	CcSEcCtD
Thiabendazole—Rash—Gemcitabine—breast cancer	0.000104	0.00071	CcSEcCtD
Thiabendazole—Dermatitis—Gemcitabine—breast cancer	0.000104	0.00071	CcSEcCtD
Thiabendazole—Tinnitus—Epirubicin—breast cancer	0.000104	0.000708	CcSEcCtD
Thiabendazole—Headache—Gemcitabine—breast cancer	0.000103	0.000706	CcSEcCtD
Thiabendazole—Flushing—Epirubicin—breast cancer	0.000103	0.000705	CcSEcCtD
Thiabendazole—Vomiting—Fluorouracil—breast cancer	0.000103	0.000704	CcSEcCtD
Thiabendazole—Dyspepsia—Docetaxel—breast cancer	0.000103	0.000704	CcSEcCtD
Thiabendazole—Hypoaesthesia—Doxorubicin—breast cancer	0.000102	0.000699	CcSEcCtD
Thiabendazole—Rash—Fluorouracil—breast cancer	0.000102	0.000699	CcSEcCtD
Thiabendazole—Dermatitis—Fluorouracil—breast cancer	0.000102	0.000698	CcSEcCtD
Thiabendazole—Decreased appetite—Docetaxel—breast cancer	0.000102	0.000695	CcSEcCtD
Thiabendazole—Hypersensitivity—Paclitaxel—breast cancer	0.000102	0.000695	CcSEcCtD
Thiabendazole—Headache—Fluorouracil—breast cancer	0.000101	0.000694	CcSEcCtD
Thiabendazole—Fatigue—Docetaxel—breast cancer	0.000101	0.000689	CcSEcCtD
Thiabendazole—Nausea—Irinotecan—breast cancer	0.0001	0.000687	CcSEcCtD
Thiabendazole—Nausea—Mitoxantrone—breast cancer	0.0001	0.000687	CcSEcCtD
Thiabendazole—Dyspepsia—Capecitabine—breast cancer	9.97e-05	0.000681	CcSEcCtD
Thiabendazole—Chills—Epirubicin—breast cancer	9.96e-05	0.000681	CcSEcCtD
Thiabendazole—Visual impairment—Doxorubicin—breast cancer	9.9e-05	0.000677	CcSEcCtD
Thiabendazole—Asthenia—Paclitaxel—breast cancer	9.9e-05	0.000677	CcSEcCtD
Thiabendazole—Decreased appetite—Capecitabine—breast cancer	9.84e-05	0.000673	CcSEcCtD
Thiabendazole—Nausea—Gemcitabine—breast cancer	9.79e-05	0.000669	CcSEcCtD
Thiabendazole—Fatigue—Capecitabine—breast cancer	9.76e-05	0.000667	CcSEcCtD
Thiabendazole—Pruritus—Paclitaxel—breast cancer	9.76e-05	0.000667	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—breast cancer	9.73e-05	0.000666	CcSEcCtD
Thiabendazole—Erythema multiforme—Doxorubicin—breast cancer	9.71e-05	0.000664	CcSEcCtD
Thiabendazole—Feeling abnormal—Docetaxel—breast cancer	9.64e-05	0.000659	CcSEcCtD
Thiabendazole—Nausea—Fluorouracil—breast cancer	9.62e-05	0.000658	CcSEcCtD
Thiabendazole—Tinnitus—Doxorubicin—breast cancer	9.58e-05	0.000655	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Docetaxel—breast cancer	9.56e-05	0.000654	CcSEcCtD
Thiabendazole—Flushing—Doxorubicin—breast cancer	9.53e-05	0.000652	CcSEcCtD
Thiabendazole—Diarrhoea—Paclitaxel—breast cancer	9.44e-05	0.000645	CcSEcCtD
Thiabendazole—Feeling abnormal—Capecitabine—breast cancer	9.33e-05	0.000638	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Capecitabine—breast cancer	9.26e-05	0.000633	CcSEcCtD
Thiabendazole—Abdominal pain—Docetaxel—breast cancer	9.24e-05	0.000632	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—breast cancer	9.24e-05	0.000632	CcSEcCtD
Thiabendazole—Chills—Doxorubicin—breast cancer	9.22e-05	0.00063	CcSEcCtD
Thiabendazole—Dizziness—Paclitaxel—breast cancer	9.12e-05	0.000624	CcSEcCtD
Thiabendazole—Vision blurred—Epirubicin—breast cancer	9.11e-05	0.000623	CcSEcCtD
Thiabendazole—Abdominal pain—Capecitabine—breast cancer	8.95e-05	0.000612	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—breast cancer	8.95e-05	0.000612	CcSEcCtD
Thiabendazole—Vomiting—Paclitaxel—breast cancer	8.77e-05	0.0006	CcSEcCtD
Thiabendazole—Rash—Paclitaxel—breast cancer	8.7e-05	0.000595	CcSEcCtD
Thiabendazole—Dermatitis—Paclitaxel—breast cancer	8.69e-05	0.000594	CcSEcCtD
Thiabendazole—Leukopenia—Epirubicin—breast cancer	8.65e-05	0.000592	CcSEcCtD
Thiabendazole—Headache—Paclitaxel—breast cancer	8.64e-05	0.000591	CcSEcCtD
Thiabendazole—Hypersensitivity—Docetaxel—breast cancer	8.61e-05	0.000589	CcSEcCtD
Thiabendazole—Confusional state—Methotrexate—breast cancer	8.5e-05	0.000581	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—breast cancer	8.43e-05	0.000576	CcSEcCtD
Thiabendazole—Vision blurred—Doxorubicin—breast cancer	8.43e-05	0.000576	CcSEcCtD
Thiabendazole—Asthenia—Docetaxel—breast cancer	8.39e-05	0.000574	CcSEcCtD
Thiabendazole—Convulsion—Epirubicin—breast cancer	8.37e-05	0.000573	CcSEcCtD
Thiabendazole—Hypersensitivity—Capecitabine—breast cancer	8.34e-05	0.00057	CcSEcCtD
Thiabendazole—Pruritus—Docetaxel—breast cancer	8.27e-05	0.000566	CcSEcCtD
Thiabendazole—Nausea—Paclitaxel—breast cancer	8.19e-05	0.00056	CcSEcCtD
Thiabendazole—Asthenia—Capecitabine—breast cancer	8.12e-05	0.000555	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—breast cancer	8.03e-05	0.000549	CcSEcCtD
Thiabendazole—Pruritus—Capecitabine—breast cancer	8.01e-05	0.000548	CcSEcCtD
Thiabendazole—Leukopenia—Doxorubicin—breast cancer	8e-05	0.000547	CcSEcCtD
Thiabendazole—Diarrhoea—Docetaxel—breast cancer	8e-05	0.000547	CcSEcCtD
Thiabendazole—Confusional state—Epirubicin—breast cancer	7.95e-05	0.000544	CcSEcCtD
Thiabendazole—Anaphylactic shock—Epirubicin—breast cancer	7.89e-05	0.000539	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—breast cancer	7.87e-05	0.000539	CcSEcCtD
Thiabendazole—Convulsion—Doxorubicin—breast cancer	7.75e-05	0.00053	CcSEcCtD
Thiabendazole—Diarrhoea—Capecitabine—breast cancer	7.75e-05	0.00053	CcSEcCtD
Thiabendazole—Dizziness—Docetaxel—breast cancer	7.73e-05	0.000529	CcSEcCtD
Thiabendazole—Anorexia—Epirubicin—breast cancer	7.52e-05	0.000514	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—breast cancer	7.49e-05	0.000512	CcSEcCtD
Thiabendazole—Dizziness—Capecitabine—breast cancer	7.49e-05	0.000512	CcSEcCtD
Thiabendazole—Vomiting—Docetaxel—breast cancer	7.43e-05	0.000508	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—breast cancer	7.42e-05	0.000507	CcSEcCtD
Thiabendazole—Rash—Docetaxel—breast cancer	7.37e-05	0.000504	CcSEcCtD
Thiabendazole—Hypotension—Epirubicin—breast cancer	7.37e-05	0.000504	CcSEcCtD
Thiabendazole—Dermatitis—Docetaxel—breast cancer	7.37e-05	0.000504	CcSEcCtD
Thiabendazole—Confusional state—Doxorubicin—breast cancer	7.36e-05	0.000503	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—breast cancer	7.33e-05	0.000501	CcSEcCtD
Thiabendazole—Headache—Docetaxel—breast cancer	7.33e-05	0.000501	CcSEcCtD
Thiabendazole—Anaphylactic shock—Doxorubicin—breast cancer	7.3e-05	0.000499	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—breast cancer	7.27e-05	0.000497	CcSEcCtD
Thiabendazole—Vomiting—Capecitabine—breast cancer	7.2e-05	0.000492	CcSEcCtD
Thiabendazole—Rash—Capecitabine—breast cancer	7.14e-05	0.000488	CcSEcCtD
Thiabendazole—Dermatitis—Capecitabine—breast cancer	7.13e-05	0.000488	CcSEcCtD
Thiabendazole—Headache—Capecitabine—breast cancer	7.09e-05	0.000485	CcSEcCtD
Thiabendazole—Somnolence—Epirubicin—breast cancer	7.01e-05	0.000479	CcSEcCtD
Thiabendazole—Anorexia—Doxorubicin—breast cancer	6.96e-05	0.000476	CcSEcCtD
Thiabendazole—Nausea—Docetaxel—breast cancer	6.95e-05	0.000475	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—breast cancer	6.94e-05	0.000475	CcSEcCtD
Thiabendazole—Dyspepsia—Epirubicin—breast cancer	6.94e-05	0.000475	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—breast cancer	6.89e-05	0.000471	CcSEcCtD
Thiabendazole—Decreased appetite—Epirubicin—breast cancer	6.86e-05	0.000469	CcSEcCtD
Thiabendazole—Hypotension—Doxorubicin—breast cancer	6.82e-05	0.000466	CcSEcCtD
Thiabendazole—Fatigue—Epirubicin—breast cancer	6.8e-05	0.000465	CcSEcCtD
Thiabendazole—Nausea—Capecitabine—breast cancer	6.72e-05	0.00046	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—breast cancer	6.66e-05	0.000456	CcSEcCtD
Thiabendazole—Feeling abnormal—Epirubicin—breast cancer	6.5e-05	0.000444	CcSEcCtD
Thiabendazole—Somnolence—Doxorubicin—breast cancer	6.49e-05	0.000444	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Epirubicin—breast cancer	6.45e-05	0.000441	CcSEcCtD
Thiabendazole—Dyspepsia—Doxorubicin—breast cancer	6.42e-05	0.000439	CcSEcCtD
Thiabendazole—Decreased appetite—Doxorubicin—breast cancer	6.34e-05	0.000434	CcSEcCtD
Thiabendazole—Fatigue—Doxorubicin—breast cancer	6.29e-05	0.00043	CcSEcCtD
Thiabendazole—Abdominal pain—Epirubicin—breast cancer	6.23e-05	0.000426	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—breast cancer	6.21e-05	0.000425	CcSEcCtD
Thiabendazole—Asthenia—Methotrexate—breast cancer	6.05e-05	0.000414	CcSEcCtD
Thiabendazole—Feeling abnormal—Doxorubicin—breast cancer	6.01e-05	0.000411	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Doxorubicin—breast cancer	5.97e-05	0.000408	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—breast cancer	5.96e-05	0.000408	CcSEcCtD
Thiabendazole—Hypersensitivity—Epirubicin—breast cancer	5.81e-05	0.000397	CcSEcCtD
Thiabendazole—Abdominal pain—Doxorubicin—breast cancer	5.77e-05	0.000395	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—breast cancer	5.77e-05	0.000394	CcSEcCtD
Thiabendazole—Asthenia—Epirubicin—breast cancer	5.66e-05	0.000387	CcSEcCtD
Thiabendazole—Pruritus—Epirubicin—breast cancer	5.58e-05	0.000382	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—breast cancer	5.57e-05	0.000381	CcSEcCtD
Thiabendazole—Diarrhoea—Epirubicin—breast cancer	5.4e-05	0.000369	CcSEcCtD
Thiabendazole—Hypersensitivity—Doxorubicin—breast cancer	5.38e-05	0.000368	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—breast cancer	5.36e-05	0.000366	CcSEcCtD
Thiabendazole—Rash—Methotrexate—breast cancer	5.31e-05	0.000363	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—breast cancer	5.31e-05	0.000363	CcSEcCtD
Thiabendazole—Headache—Methotrexate—breast cancer	5.28e-05	0.000361	CcSEcCtD
Thiabendazole—Asthenia—Doxorubicin—breast cancer	5.24e-05	0.000358	CcSEcCtD
Thiabendazole—Dizziness—Epirubicin—breast cancer	5.22e-05	0.000357	CcSEcCtD
Thiabendazole—Pruritus—Doxorubicin—breast cancer	5.16e-05	0.000353	CcSEcCtD
Thiabendazole—Vomiting—Epirubicin—breast cancer	5.01e-05	0.000343	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—breast cancer	5.01e-05	0.000342	CcSEcCtD
Thiabendazole—Diarrhoea—Doxorubicin—breast cancer	4.99e-05	0.000341	CcSEcCtD
Thiabendazole—Rash—Epirubicin—breast cancer	4.97e-05	0.00034	CcSEcCtD
Thiabendazole—Dermatitis—Epirubicin—breast cancer	4.97e-05	0.00034	CcSEcCtD
Thiabendazole—Headache—Epirubicin—breast cancer	4.94e-05	0.000338	CcSEcCtD
Thiabendazole—Dizziness—Doxorubicin—breast cancer	4.83e-05	0.00033	CcSEcCtD
Thiabendazole—Nausea—Epirubicin—breast cancer	4.68e-05	0.00032	CcSEcCtD
Thiabendazole—Vomiting—Doxorubicin—breast cancer	4.64e-05	0.000317	CcSEcCtD
Thiabendazole—Rash—Doxorubicin—breast cancer	4.6e-05	0.000315	CcSEcCtD
Thiabendazole—Dermatitis—Doxorubicin—breast cancer	4.6e-05	0.000314	CcSEcCtD
Thiabendazole—Headache—Doxorubicin—breast cancer	4.57e-05	0.000313	CcSEcCtD
Thiabendazole—Nausea—Doxorubicin—breast cancer	4.33e-05	0.000296	CcSEcCtD
Thiabendazole—CYP1A1—Metabolism—SYNJ2—breast cancer	4.19e-05	0.000585	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—NCOA1—breast cancer	4.18e-05	0.000584	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP19A1—breast cancer	4.12e-05	0.000575	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—breast cancer	4.11e-05	0.000574	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—breast cancer	4.1e-05	0.000573	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP19A1—breast cancer	4.07e-05	0.000568	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—breast cancer	4.02e-05	0.000562	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—breast cancer	4.02e-05	0.000562	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	3.98e-05	0.000555	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	3.98e-05	0.000555	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NDUFS3—breast cancer	3.9e-05	0.000544	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—COMT—breast cancer	3.83e-05	0.000535	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—breast cancer	3.83e-05	0.000535	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—breast cancer	3.83e-05	0.000535	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTP1—breast cancer	3.81e-05	0.000532	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—breast cancer	3.8e-05	0.000531	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—COMT—breast cancer	3.78e-05	0.000528	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HADHB—breast cancer	3.77e-05	0.000526	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTP1—breast cancer	3.76e-05	0.000525	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—MED12—breast cancer	3.75e-05	0.000523	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CHST9—breast cancer	3.66e-05	0.000512	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.58e-05	0.0005	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—GSTM1—breast cancer	3.51e-05	0.000489	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	3.48e-05	0.000486	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COX11—breast cancer	3.47e-05	0.000485	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—GSTM1—breast cancer	3.46e-05	0.000483	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—breast cancer	3.45e-05	0.000481	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.42e-05	0.000477	CbGpPWpGaD
Thiabendazole—CYP1A2—Biological oxidations—CYP1A1—breast cancer	3.32e-05	0.000464	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.31e-05	0.000463	CbGpPWpGaD
Thiabendazole—CYP1A2—Metapathway biotransformation—CYP1A1—breast cancer	3.28e-05	0.000457	CbGpPWpGaD
Thiabendazole—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—breast cancer	3.23e-05	0.000451	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	3.21e-05	0.000447	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CDA—breast cancer	3.18e-05	0.000444	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SHMT1—breast cancer	3.18e-05	0.000444	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.14e-05	0.000438	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.11e-05	0.000434	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	3.1e-05	0.000433	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A5—breast cancer	3.06e-05	0.000427	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLCO1B1—breast cancer	3.06e-05	0.000427	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	2.99e-05	0.000417	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—APRT—breast cancer	2.95e-05	0.000412	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—FASN—breast cancer	2.9e-05	0.000405	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—breast cancer	2.89e-05	0.000403	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX2—breast cancer	2.86e-05	0.000399	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—breast cancer	2.82e-05	0.000394	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ESRRA—breast cancer	2.78e-05	0.000388	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ANGPTL4—breast cancer	2.78e-05	0.000388	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—breast cancer	2.76e-05	0.000385	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SYNJ2—breast cancer	2.67e-05	0.000373	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.64e-05	0.000369	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HADHB—breast cancer	2.63e-05	0.000368	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPI—breast cancer	2.63e-05	0.000368	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.52e-05	0.000352	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDH1A1—breast cancer	2.51e-05	0.000351	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDH7A1—breast cancer	2.51e-05	0.000351	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NDUFS3—breast cancer	2.49e-05	0.000347	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.48e-05	0.000347	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PHGDH—breast cancer	2.41e-05	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—UMPS—breast cancer	2.41e-05	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ADSL—breast cancer	2.41e-05	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FHL2—breast cancer	2.41e-05	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NME1—breast cancer	2.41e-05	0.000336	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—MED12—breast cancer	2.39e-05	0.000334	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BRIP1—breast cancer	2.36e-05	0.00033	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HPSE—breast cancer	2.36e-05	0.00033	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—LDHB—breast cancer	2.36e-05	0.00033	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CHST9—breast cancer	2.34e-05	0.000326	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	2.28e-05	0.000319	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCC1—breast cancer	2.24e-05	0.000313	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMMR—breast cancer	2.24e-05	0.000313	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA3—breast cancer	2.24e-05	0.000313	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	2.22e-05	0.00031	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COX11—breast cancer	2.22e-05	0.000309	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	2.18e-05	0.000304	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PPARGC1B—breast cancer	2.17e-05	0.000303	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—breast cancer	2.11e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.11e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.11e-05	0.000295	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CA9—breast cancer	2.05e-05	0.000286	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA4—breast cancer	2.05e-05	0.000286	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SHMT1—breast cancer	2.03e-05	0.000283	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CDA—breast cancer	2.03e-05	0.000283	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.02e-05	0.000282	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	2e-05	0.000279	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA2—breast cancer	2e-05	0.000279	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX2—breast cancer	2e-05	0.000279	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	1.98e-05	0.000276	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX4—breast cancer	1.97e-05	0.000275	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SULT1A1—breast cancer	1.97e-05	0.000275	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A5—breast cancer	1.95e-05	0.000272	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLCO1B1—breast cancer	1.95e-05	0.000272	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—IDH1—breast cancer	1.93e-05	0.000269	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTA1—breast cancer	1.93e-05	0.000269	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	1.91e-05	0.000266	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NAT2—breast cancer	1.9e-05	0.000266	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—APRT—breast cancer	1.88e-05	0.000263	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—FASN—breast cancer	1.85e-05	0.000258	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—breast cancer	1.84e-05	0.000257	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ANGPTL4—breast cancer	1.77e-05	0.000247	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ESRRA—breast cancer	1.77e-05	0.000247	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.72e-05	0.00024	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	1.68e-05	0.000235	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPI—breast cancer	1.68e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HADHB—breast cancer	1.68e-05	0.000234	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—DPYD—breast cancer	1.67e-05	0.000233	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MED12—breast cancer	1.67e-05	0.000233	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALDOA—breast cancer	1.64e-05	0.000229	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.61e-05	0.000224	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.6e-05	0.000224	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.6e-05	0.000224	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA3—breast cancer	1.6e-05	0.000223	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A2—breast cancer	1.58e-05	0.000221	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.58e-05	0.000221	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.57e-05	0.000219	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCG2—breast cancer	1.55e-05	0.000217	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CPT1A—breast cancer	1.55e-05	0.000217	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTR—breast cancer	1.55e-05	0.000217	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ADSL—breast cancer	1.54e-05	0.000214	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NME1—breast cancer	1.54e-05	0.000214	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FHL2—breast cancer	1.54e-05	0.000214	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—UMPS—breast cancer	1.54e-05	0.000214	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PHGDH—breast cancer	1.54e-05	0.000214	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HPGDS—breast cancer	1.52e-05	0.000212	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HBA1—breast cancer	1.51e-05	0.000211	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BRIP1—breast cancer	1.51e-05	0.00021	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HPSE—breast cancer	1.51e-05	0.00021	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—LDHB—breast cancer	1.51e-05	0.00021	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTT1—breast cancer	1.48e-05	0.000206	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ACHE—breast cancer	1.48e-05	0.000206	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA3—breast cancer	1.43e-05	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMMR—breast cancer	1.43e-05	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCC1—breast cancer	1.43e-05	0.000199	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP17A1—breast cancer	1.4e-05	0.000195	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ENO1—breast cancer	1.38e-05	0.000193	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS1—breast cancer	1.38e-05	0.000193	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PPARGC1B—breast cancer	1.38e-05	0.000193	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.38e-05	0.000192	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.36e-05	0.00019	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP2D6—breast cancer	1.36e-05	0.000189	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.35e-05	0.000188	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.35e-05	0.000188	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA2—breast cancer	1.33e-05	0.000186	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA4—breast cancer	1.31e-05	0.000182	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CA9—breast cancer	1.31e-05	0.000182	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—FASN—breast cancer	1.29e-05	0.00018	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.29e-05	0.00018	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—BCHE—breast cancer	1.29e-05	0.000179	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.28e-05	0.000178	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX2—breast cancer	1.27e-05	0.000178	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA2—breast cancer	1.27e-05	0.000178	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC5A5—breast cancer	1.27e-05	0.000177	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX4—breast cancer	1.26e-05	0.000175	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SULT1A1—breast cancer	1.26e-05	0.000175	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—IDH1—breast cancer	1.23e-05	0.000171	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTA1—breast cancer	1.23e-05	0.000171	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—SLC2A1—breast cancer	1.23e-05	0.000171	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NQO1—breast cancer	1.23e-05	0.000171	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NAT2—breast cancer	1.21e-05	0.000169	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.2e-05	0.000168	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP3A4—breast cancer	1.2e-05	0.000167	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.19e-05	0.000166	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP1B1—breast cancer	1.18e-05	0.000164	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HSP90AA1—breast cancer	1.15e-05	0.000161	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOA1—breast cancer	1.12e-05	0.000157	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CYP19A1—breast cancer	1.11e-05	0.000154	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—STK11—breast cancer	1.11e-05	0.000154	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.1e-05	0.000153	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MED12—breast cancer	1.06e-05	0.000149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—DPYD—breast cancer	1.06e-05	0.000149	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALDOA—breast cancer	1.05e-05	0.000146	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.04e-05	0.000145	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—COMT—breast cancer	1.03e-05	0.000143	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTP1—breast cancer	1.02e-05	0.000143	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA3—breast cancer	1.02e-05	0.000142	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A2—breast cancer	1.01e-05	0.000141	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—HMOX1—breast cancer	1.01e-05	0.000141	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ITPR1—breast cancer	1.01e-05	0.000141	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.99e-06	0.00014	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTR—breast cancer	9.89e-06	0.000138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCG2—breast cancer	9.89e-06	0.000138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CPT1A—breast cancer	9.89e-06	0.000138	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HPGDS—breast cancer	9.7e-06	0.000135	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ABCB1—breast cancer	9.68e-06	0.000135	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HBA1—breast cancer	9.64e-06	0.000135	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—TYMS—breast cancer	9.51e-06	0.000133	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ACHE—breast cancer	9.41e-06	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTT1—breast cancer	9.41e-06	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PLA2G4A—breast cancer	9.4e-06	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GSTM1—breast cancer	9.4e-06	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NCOR1—breast cancer	9.4e-06	0.000131	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—GPX1—breast cancer	9e-06	0.000126	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP17A1—breast cancer	8.91e-06	0.000124	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ERCC2—breast cancer	8.84e-06	0.000123	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ENO1—breast cancer	8.82e-06	0.000123	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS1—breast cancer	8.82e-06	0.000123	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.79e-06	0.000123	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.67e-06	0.000121	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP2D6—breast cancer	8.65e-06	0.000121	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA2—breast cancer	8.49e-06	0.000119	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—MTHFR—breast cancer	8.31e-06	0.000116	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—FASN—breast cancer	8.23e-06	0.000115	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—BCHE—breast cancer	8.2e-06	0.000114	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC5A5—breast cancer	8.1e-06	0.000113	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NQO1—breast cancer	7.82e-06	0.000109	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—SLC2A1—breast cancer	7.82e-06	0.000109	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—CAV1—breast cancer	7.66e-06	0.000107	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.66e-06	0.000107	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP3A4—breast cancer	7.63e-06	0.000106	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.59e-06	0.000106	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1B1—breast cancer	7.5e-06	0.000105	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HSP90AA1—breast cancer	7.35e-06	0.000103	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.32e-06	0.000102	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOA1—breast cancer	7.15e-06	9.99e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—STK11—breast cancer	7.05e-06	9.84e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP19A1—breast cancer	7.05e-06	9.84e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CG—breast cancer	6.98e-06	9.75e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.62e-06	9.24e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—COMT—breast cancer	6.55e-06	9.15e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTP1—breast cancer	6.52e-06	9.11e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—HMOX1—breast cancer	6.43e-06	8.98e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ITPR1—breast cancer	6.42e-06	8.96e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ABCB1—breast cancer	6.17e-06	8.62e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CD—breast cancer	6.14e-06	8.57e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—TYMS—breast cancer	6.06e-06	8.47e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—ALB—breast cancer	6.06e-06	8.46e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PLA2G4A—breast cancer	5.99e-06	8.37e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GSTM1—breast cancer	5.99e-06	8.37e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NCOR1—breast cancer	5.99e-06	8.37e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—NOS3—breast cancer	5.79e-06	8.09e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—GPX1—breast cancer	5.74e-06	8.01e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CYP1A1—breast cancer	5.68e-06	7.93e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ERCC2—breast cancer	5.64e-06	7.87e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CB—breast cancer	5.35e-06	7.47e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTGS2—breast cancer	5.3e-06	7.4e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—MTHFR—breast cancer	5.3e-06	7.4e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—CAV1—breast cancer	4.89e-06	6.82e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.67e-06	6.52e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PTEN—breast cancer	4.62e-06	6.45e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CG—breast cancer	4.45e-06	6.21e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CD—breast cancer	3.91e-06	5.46e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—ALB—breast cancer	3.86e-06	5.39e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—NOS3—breast cancer	3.69e-06	5.16e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CB—breast cancer	3.41e-06	4.76e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTGS2—breast cancer	3.38e-06	4.72e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—PIK3CA—breast cancer	3.26e-06	4.55e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PTEN—breast cancer	2.95e-06	4.11e-05	CbGpPWpGaD
Thiabendazole—CYP1A1—Metabolism—AKT1—breast cancer	2.66e-06	3.72e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—PIK3CA—breast cancer	2.08e-06	2.9e-05	CbGpPWpGaD
Thiabendazole—CYP1A2—Metabolism—AKT1—breast cancer	1.7e-06	2.37e-05	CbGpPWpGaD
